| 2022-11-07 | +26.6% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2022-11-07 | +26.6% | legal | SEC EDGAR | CERT 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2025-11-07 | -25.2% | earnings | Seeking Alpha | Certara narrows 2025 revenue outlook to $415M–$420M as Tier 1 services soften while software and QSP show resilience |
| 2025-11-07 | -25.2% | earnings | Seeking Alpha | Certara, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-07 | -25.2% | earnings | Seeking Alpha | Certara, Inc. (CERT) Q3 2025 Earnings Call Transcript |
| 2025-11-06 | -24.1% | earnings | Seeking Alpha | Certara Non-GAAP EPS of $0.14 beats by $0.03, revenue of $104.6M in-line |
| 2025-11-06 | -24.1% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2023-03-01 | +19.0% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2023-03-01 | +19.0% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2022-08-09 | -17.3% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2025-08-07 | +14.1% | earnings | Seeking Alpha | Certara signals full year 8–10% revenue growth outlook as AI and QSP momentum builds |
| 2025-08-07 | +14.1% | earnings | Seeking Alpha | Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript |
| 2025-08-07 | +14.1% | news | Yahoo Finance | Certara, Inc. (CERT): A Bull Case Theory - Yahoo Finance |
| 2022-03-01 | -13.7% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2025-08-06 | +13.5% | earnings | Seeking Alpha | Certara Non-GAAP EPS of $0.07 misses by $0.03, revenue of $104.6M beats by $0.52M |
| 2025-08-06 | +13.5% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2022-08-12 | -13.5% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2024-08-06 | -12.9% | legal | SEC EDGAR | CERT 8-K: 2.02 (SEC Filing) |
| 2026-02-02 | -11.5% | news | Gotrade | Certara, Inc. Common Stock (CERT) Stock Price Today & Analysis - Gotrade |
| 2025-05-05 | -11.1% | earnings | Seeking Alpha | Certara signals 8-10% revenue growth for 2025, driven by software and biosimulation demand |
| 2025-05-05 | -11.1% | earnings | Seeking Alpha | Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript |
| 2025-05-05 | -11.1% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2025-04-12 | +10.6% | news | Finviz | Why Certara Inc. (CERT) Surged On Friday? - Finviz |
| 2023-08-09 | -9.4% | legal | SEC EDGAR | CERT 8-K: 2.02 (SEC Filing) |
| 2023-05-08 | -9.1% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +8.5% | earnings | Seeking Alpha | Certara outlines flat to 4% 2026 revenue growth as new CEO signals operational overhaul and $10M cost avoidance |
| 2026-02-26 | +8.5% | earnings | Seeking Alpha | Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript |
| 2026-02-26 | +8.5% | earnings | Seeking Alpha | Certara, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-26 | +8.5% | earnings | Seeking Alpha | Certara Non-GAAP EPS of $0.09 misses by $0.01, revenue of $103.6M beats by $0.37M |
| 2026-02-26 | +8.5% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +8.5% | earnings | Yahoo Finance | Certara, Inc. (CERT) Q4 Earnings Lag Estimates - Yahoo Finance |
| 2026-02-26 | +8.5% | earnings | Quiver Quantitative | CERTARA ($CERT) Releases Q4 2025 Earnings - Quiver Quantitative |
| 2026-02-26 | +8.5% | news | Stock Titan | Drug-modeling firm Certara targets 0-4% growth after $419M sales year - Stock Titan |
| 2026-01-05 | +8.2% | earnings | The Motley Fool | Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway - The Motley Fool |
| 2025-01-15 | +7.9% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2021-05-06 | -7.6% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2024-05-07 | -7.4% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2026-01-27 | -7.4% | earnings | Yahoo Finance | Lower-Than-Expected Service Bookings Impacted Certara (CERT) in Q4 - Yahoo Finance |
| 2026-02-03 | -7.0% | news | Investing.com | Certara stock hits 52-week low at 8.02 USD - Investing.com |
| 2026-02-03 | -7.0% | news | Benzinga | Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivo - Benzinga |
| 2026-04-08 | -6.9% | analyst | Simply Wall St. | How The Certara (CERT) Story Is Evolving As Price Targets Reset And Growth Plans Lag |
| 2026-03-31 | -6.9% | legal | SEC EDGAR | CERT 8-K: 5.02 (SEC Filing) |
| 2026-03-31 | -6.9% | news | Stock Titan | Cynthia Collins to leave Certara (CERT) board and Audit Committee in May 2026 - Stock Titan |
| 2025-04-14 | +6.8% | legal | SEC EDGAR | CERT 8-K: 1.01, 2.02 (SEC Filing) |
| 2025-04-14 | +6.8% | legal | GuruFocus | Certara (CERT) Explores Strategic Options for Regulatory Services Unit | CERT Stock News - GuruFocus |
| 2025-12-11 | -6.7% | executive | Seeking Alpha | Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook |
| 2025-12-11 | -6.7% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2025-12-11 | -6.7% | earnings | Stock Titan | Certara (Nasdaq: CERT) appoints Jon Resnick CEO as Feehery steps down - Stock Titan |
| 2025-10-15 | +6.6% | news | Seeking Alpha | Why Investors Should Consider Certara Again |
| 2025-10-15 | +6.6% | news | Seeking Alpha | Why Investors Should Consider Certara Again (NASDAQ:CERT) - Seeking Alpha |
| 2022-07-13 | -6.6% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2024-02-29 | +6.5% | legal | SEC EDGAR | CERT 8-K: 2.02 (SEC Filing) |
| 2026-01-29 | -6.0% | earnings | Stock Titan | Certara to post 2025 earnings Feb. 26, with 8:30 a.m. ET call - Stock Titan |
| 2026-03-10 | -5.1% | news | Seeking Alpha | Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript |
| 2025-09-09 | -4.7% | news | Seeking Alpha | Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript) |
| 2026-01-06 | +4.7% | analyst | Investing.com | Leerink Partners upgrades Certara stock rating to Outperform - Investing.com |
| 2026-03-03 | +4.4% | news | Seeking Alpha | Certara, Inc. (CERT) Presents at TD Cowen 46th Annual Health Care Conference Transcript |
| 2026-03-03 | +4.4% | legal | Stock Titan | FDA accepts virtual-patient data so leukemia drug avoids 10 trials - Stock Titan |
| 2025-07-08 | +4.4% | expansion | Seeking Alpha | Certara expands clinical technology partnership with Merck |
| 2025-08-05 | -4.4% | earnings | Seeking Alpha | Certara Q2 2025 Earnings Preview |
| 2021-11-09 | -4.4% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2025-11-11 | -4.2% | news | Seeking Alpha | Certara, Inc. (CERT) Presents at UBS Global Healthcare Conference 2025 - Slideshow |
| 2025-10-10 | -4.1% | news | Quiver Quantitative | Certara, Inc. to Release Third Quarter 2025 Financial Results on November 6th - Quiver Quantitative |
| 2026-02-27 | +4.1% | news | Stock Titan | Drug development firm Certara lines up three March investor talks - Stock Titan |
| 2021-10-04 | -4.1% | legal | SEC EDGAR | CERT 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-22 | -3.8% | legal | MT Newswires | Certara to Sell Regulatory, Medical Writing Business to Veristat for $135 Million |
| 2026-04-22 | -3.8% | M&A | Business Wire | Veristat to Acquire Certara’s Regulatory and Medical Writing Business |
| 2026-04-22 | -3.8% | expansion | GlobeNewswire | Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat |
| 2026-04-22 | -3.8% | legal | Seeking Alpha | Certara to sell regulatory and medical writing business for up to $135M |
| 2026-04-22 | -3.8% | legal | SEC EDGAR | CERT 8-K: 1.01 and (SEC Filing) |
| 2026-04-22 | -3.8% | news | Stock Titan | Certara is selling a 220-employee unit to fund AI drug tools - Stock Titan |
| 2026-04-22 | -3.8% | legal | Seeking Alpha | Certara to sell regulatory and medical writing business (CERT) - Seeking Alpha |
| 2026-04-22 | -3.8% | M&A | Stock Titan | Certara (NASDAQ: CERT) divests regulatory and medical writing unit to Veristat - Stock Titan |
| 2021-06-22 | -3.5% | legal | SEC EDGAR | CERT 8-K: 1.01 and (SEC Filing) |
| 2026-03-30 | -3.4% | earnings | MarketBeat | Certara (NASDAQ:CERT) Hits New 52-Week Low - Here's What Happened - MarketBeat |
| 2026-03-15 | -3.4% | news | Simply Wall St. | Is Certara (CERT) Offering Opportunity After Prolonged Share Price Weakness |
| 2026-03-14 | -3.4% | earnings | MarketBeat | Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip |
| 2026-04-06 | +3.4% | news | Stock Titan | Wasatch Advisors reports 5.27M shares in Certara (NASDAQ: CERT) Amendment No.3 - Stock Titan |
| 2026-04-06 | +3.4% | news | Stock Titan | Wasatch Advisors holds 5.27M Certara shares (NASDAQ: CERT) - Stock Titan |
| 2024-11-06 | +3.3% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2022-07-25 | +3.3% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2026-02-10 | -3.1% | analyst | Yahoo Finance | Analyst Sentiment on Certara (CERT) Remains Moderately Bullish Despite Sector Volatility - Yahoo Finance |
| 2026-02-12 | -3.0% | news | simplywall.st | Certara, Inc.'s (NASDAQ:CERT) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - simplywall.st |
| 2025-07-11 | -3.0% | M&A | Seeking Alpha | Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences |
| 2025-07-11 | -3.0% | M&A | Seeking Alpha | Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences (NASDAQ:CERT) - Seeking Alpha |
| 2024-10-16 | +2.8% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2023-03-31 | -2.8% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2026-03-09 | -2.6% | news | Seeking Alpha | Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript |
| 2022-12-23 | -2.5% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2026-03-26 | -2.3% | news | Stock Titan | Vanguard disaggregates holdings after realignment for Certara Inc (CERT) - Stock Titan |
| 2026-03-22 | +2.2% | news | Stock Titan | If You Invested $1,000 in Certara, Inc. (CERT) - Stock Titan |
| 2023-04-04 | -2.1% | analyst | Seeking Alpha | Certara stock downgraded at Barclays on valuation (NASDAQ:CERT) - Seeking Alpha |
| 2022-08-15 | -2.0% | legal | SEC EDGAR | CERT 8-K: 8.01 and (SEC Filing) |
| 2025-04-21 | +2.0% | earnings | MarketBeat | 3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat |
| 2025-11-18 | +1.9% | news | Seeking Alpha | Certara, Inc. (CERT) Presents at Stephens Annual Investment Conference 2025 Transcript |
| 2025-11-18 | +1.9% | news | Seeking Alpha | Certara, Inc. (CERT) Presents at Jefferies London Healthcare Conference 2025 Transcript |
| 2024-06-26 | +1.9% | legal | SEC EDGAR | CERT 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-01-19 | +1.8% | news | AD HOC NEWS | Certara Inc EXPOSED: The Quiet Pharma Tech Power Move Wall Street Is Sleeping On - AD HOC NEWS |
| 2025-02-26 | +1.7% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | +1.7% | news | GlobeNewswire | Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 |
| 2026-04-09 | +1.7% | earnings | Stock Titan | Certara sets May 11 earnings release, webcast starts at 8:30 ET - Stock Titan |
| 2025-11-05 | -1.7% | earnings | Seeking Alpha | Certara Q3 2025 Earnings Preview |
| 2022-05-05 | +1.6% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2021-08-05 | +1.5% | legal | SEC EDGAR | CERT 8-K: 2.02 and (SEC Filing) |
| 2021-08-05 | +1.5% | legal | SEC EDGAR | CERT 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-09-10 | -1.5% | news | Seeking Alpha | Certara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2022-04-07 | +1.4% | legal | SEC EDGAR | CERT 8-K: 5.02 and (SEC Filing) |
| 2022-12-08 | +1.4% | legal | SEC EDGAR | CERT 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-02-25 | +1.4% | earnings | Seeking Alpha | Certara Q4 2025 Earnings Preview |
| 2026-04-23 | -1.3% | M&A | The Globe and Mail | Certara to Divest Regulatory and Medical Writing Business - The Globe and Mail |
| 2026-04-23 | -1.3% | M&A | Sahm | Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm |
| 2026-04-23 | -1.3% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Certara (CERT) stock considered stable (+2.26%) 2026-04-22 - Price Surge - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-02 | -1.3% | earnings | GlobeNewswire | Cerrado Gold Announces Q4 and Annual 2025 Financial Results |
| 2023-11-08 | +1.3% | legal | SEC EDGAR | CERT 8-K: 2.02 (SEC Filing) |
| 2025-03-05 | -1.2% | legal | SEC EDGAR | CERT 8-K: 5.02 (SEC Filing) |
| 2023-12-12 | -1.2% | M&A | marketscreener.com | Certara, Inc. (NasdaqGS : CERT) acquired Applied BioMath, LLC for $36.6 million. - marketscreener.com |
| 2025-03-20 | +0.9% | news | Intellectia AI | CERT Forecast — Price Prediction for 2026. Should I Buy CERT? - Intellectia AI |
| 2021-06-14 | -0.9% | legal | SEC EDGAR | CERT 8-K: 5.02 (SEC Filing) |
| 2026-04-20 | +0.5% | earnings | GlobeNewswire | Cerrado Gold Announces Q1 2026 Production Results at Its Minera Don Nicolas Mine in Argentina |
| 2026-04-17 | -0.5% | earnings | MarketBeat | Certara, Inc. $CERT Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat |
| 2026-04-17 | -0.5% | news | Cổng thông tin điện tử Tỉnh Sơn La | Why Certara (CERT) Stock Is Rising Now (Investor Interest) 2026-04-16 - Pro Trader Recommendations - Cổng thông tin điện tử Tỉnh Sơn La |
| 2021-07-15 | -0.5% | legal | SEC EDGAR | CERT 8-K: 5.02 (SEC Filing) |
| 2026-04-05 | +0.5% | legal | Stock Titan | CERT SEC Filings - Certara, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-03 | +0.5% | news | Stock Titan | Certara (NASDAQ: CERT) executive gains shares as RSUs and PSUs vest - Stock Titan |
| 2026-04-03 | +0.5% | news | Stock Titan | [Form 4] Certara, Inc. Insider Trading Activity - Stock Titan |
| 2026-04-03 | +0.5% | news | Stock Titan | Certara (CERT) executive exercises 10,849 RSUs, uses 2,642 shares for tax withholding - Stock Titan |
| 2026-04-03 | +0.5% | executive | Stock Titan | Certara (CERT) CFO adds 50,605 shares from RSU and PSU vesting plus grant - Stock Titan |
| 2025-11-04 | -0.3% | news | Stock Titan | Certara (NASDAQ: CERT) Debuts TFL Studio, First Phoenix Cloud Module; TFLs 50% Faster - Stock Titan |
| 2026-03-20 | +0.2% | news | Zacks | Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock? |
| 2024-03-12 | -0.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-10-16 | +0.1% | legal | SEC EDGAR | CERT 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-26 | — | news | Seeking Alpha | Certara: An Interesting Situation To Keep Track Off |
| 2026-04-26 | — | news | Seeking Alpha | Certara: An Interesting Situation To Keep Track Off (NASDAQ:CERT) - Seeking Alpha |
| 2026-04-25 | — | news | MEXC Exchange | CERT Price Today: Certara, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange |